IgG

IgG N-glycans N-glycome glycosylation pemphigus rituximab sialic acid

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
22 Jul 2022
Historique:
received: 25 05 2022
revised: 27 06 2022
accepted: 18 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Pemphigus is a life-threatening auto-immune blistering disease of the skin and mucous membrane that is caused by the production of auto-antibodies (auto-Abs) directed against adhesion proteins: desmoglein 1 and 3. We demonstrated in the "Ritux3" trial, the high efficacy of rituximab, an anti-CD20 recombinant monoclonal antibody, as the first-line treatment for pemphigus. However, 25% of patients relapsed during the six-month period after rituximab treatment. These early relapses were associated with a lower decrease in anti-desmoglein auto-Abs after the initial cycle of rituximab. The

Identifiants

pubmed: 35892674
pii: biomedicines10081774
doi: 10.3390/biomedicines10081774
pmc: PMC9330150
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

EBioMedicine. 2017 Mar;17:108-118
pubmed: 28169190
Lancet. 2017 May 20;389(10083):2031-2040
pubmed: 28342637
Curr Top Microbiol Immunol. 2019;423:63-75
pubmed: 30805712
Biomedicines. 2021 Oct 08;9(10):
pubmed: 34680528
J Invest Dermatol. 2018 Dec;138(12):2666-2668
pubmed: 30472996
MAbs. 2013 Jul-Aug;5(4):614-9
pubmed: 23751752
J Immunol. 2016 Feb 15;196(4):1435-41
pubmed: 26851295
Gut. 1990 Apr;31(4):431-4
pubmed: 2338269
Nat Rev Rheumatol. 2017 Oct;13(10):621-630
pubmed: 28905852
J Exp Med. 1988 May 1;167(5):1731-6
pubmed: 3367097
Front Immunol. 2018 Jun 06;9:1183
pubmed: 29928274
Arthritis Rheum. 2011 Jul;63(7):2105-15
pubmed: 21437874
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12669-74
pubmed: 21768335
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4081-2
pubmed: 18344326
J Immunol. 1999 Feb 15;162(4):2162-70
pubmed: 9973491
Proteomics. 2007 Nov;7(22):4070-81
pubmed: 17994628
Glycobiology. 2019 Aug 20;29(9):620-624
pubmed: 31184695
Cell Immunol. 2018 Nov;333:65-79
pubmed: 30107893
Cell. 2018 Jan 25;172(3):564-577.e13
pubmed: 29275858
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
MAbs. 2019 Feb/Mar;11(2):350-372
pubmed: 30466347
J Immunol. 2019 Mar 1;202(5):1582-1594
pubmed: 30683704
Adv Med Sci. 2016 Sep;61(2):193-197
pubmed: 26876088
Ann Rheum Dis. 2009 Aug;68(8):1360-5
pubmed: 18772190
J Invest Dermatol. 2005 May;124(5):939-46
pubmed: 15854034
Lupus. 2016 Jul;25(8):934-42
pubmed: 27252272
J Invest Dermatol. 2019 Jan;139(1):31-37
pubmed: 30301637
JAMA Dermatol. 2020 May 1;156(5):545-552
pubmed: 32186656
Trends Immunol. 2017 May;38(5):358-372
pubmed: 28385520
Lancet. 1988 Apr 30;1(8592):966-9
pubmed: 2896829
Rejuvenation Res. 2007 Dec;10(4):521-531a
pubmed: 18047421
Glycoconj J. 1998 Jul;15(7):683-9
pubmed: 9881774
Annu Rev Immunol. 2007;25:21-50
pubmed: 17029568
Eur J Immunol. 2014 May;44(5):1444-53
pubmed: 24505033
Nat Immunol. 2014 Aug;15(8):707-16
pubmed: 25045879
Glycobiology. 2020 Mar 20;30(4):202-213
pubmed: 31504525
J Biol Chem. 2003 Jan 31;278(5):3466-73
pubmed: 12427744
J Proteome Res. 2009 Feb;8(2):694-701
pubmed: 19035662
Eur J Immunol. 2012 Apr;42(4):826-30
pubmed: 22278120
Science. 2006 Aug 4;313(5787):670-3
pubmed: 16888140
Ann Rheum Dis. 2015 Jan;74(1):234-41
pubmed: 24106048
Sci Rep. 2020 Feb 20;10(1):3051
pubmed: 32080262
J Invest Dermatol. 1997 Oct;109(4):592-6
pubmed: 9326396
Arthritis Rheumatol. 2015 Nov;67(11):2978-89
pubmed: 26200652
J Biol Chem. 2002 Jul 26;277(30):26733-40
pubmed: 11986321
J Invest Dermatol. 2021 Sep;141(9):2132-2140.e1
pubmed: 33766510
Biochim Biophys Acta. 2016 Aug;1860(8):1728-38
pubmed: 27038647
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15005-9
pubmed: 18815375
Lancet. 2019 Sep 7;394(10201):882-894
pubmed: 31498102
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):1152-1158
pubmed: 28263871
J Gerontol A Biol Sci Med Sci. 2014 Jul;69(7):779-89
pubmed: 24325898
Eur J Nutr. 2021 Oct;60(7):3727-3741
pubmed: 33770218
Drugs. 2015 Feb;75(3):271-84
pubmed: 25655250

Auteurs

Guillaume Font (G)

Université de Rouen Normandie, Inserm U1234, CHU Rouen, Department of Dermatology, F-76000 Rouen, France.

Marie-Laure Walet-Balieu (ML)

Université de Rouen Normandie, Laboratoire Glyco-MEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, F-76000 Rouen, France.

Marie Petit (M)

Université de Rouen Normandie, Inserm U1234, F-76000 Rouen, France.

Carole Burel (C)

Université de Rouen Normandie, Laboratoire Glyco-MEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, F-76000 Rouen, France.

Maud Maho-Vaillant (M)

Université de Rouen Normandie, Inserm U1234, CHU Rouen, Department of Dermatology, F-76000 Rouen, France.

Vivien Hébert (V)

Université de Rouen Normandie, Inserm U1234, CHU Rouen, Department of Dermatology, F-76000 Rouen, France.

Philippe Chan (P)

Université de Rouen Normandie, INSERM US 51, CNRS UAR 2026, HeRacLeS-PISSARO, Normandie Université, F-76000 Rouen, France.

Manuel Fréret (M)

Université de Rouen Normandie, Inserm U1234, CHU Rouen, Department of Rhumatology, F-76000 Rouen, France.

Olivier Boyer (O)

Université de Rouen Normandie, Inserm U1234, CHU Rouen, Department of Immunology and Biotherapy, F-76000 Rouen, France.

Pascal Joly (P)

Université de Rouen Normandie, Inserm U1234, CHU Rouen, Department of Dermatology, F-76000 Rouen, France.

Sébastien Calbo (S)

Université de Rouen Normandie, Inserm U1234, F-76000 Rouen, France.

Muriel Bardor (M)

Université de Rouen Normandie, Laboratoire Glyco-MEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, F-76000 Rouen, France.
Université de Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.

Marie-Laure Golinski (ML)

Université de Rouen Normandie, Inserm U1234, CHU Rouen, Department of Dermatology, F-76000 Rouen, France.

Classifications MeSH